Skip to main content
. 2022 Oct 14;14(20):5030. doi: 10.3390/cancers14205030

Figure 1.

Figure 1

Flow chart. * Lymphopenia (n = 8), bleeding event without cytopenia (n = 4), hemophagocytic lymphohistiocytosis (n = 1), lymph node enlargement (n = 1), no cytopenia after experts’ review (n = 1). ICI: Immune checkpoint inhibitor, irAEs: Immune-related adverse events.